# A Study to Assess Drug-Drug Interaction Between ABBV-903 and Midazolam in Adult Healthy Volunteers

> **NCT05895266** · PHASE1 · COMPLETED · sponsor: **AbbVie** · enrollment: 24 (actual)

## Conditions studied

- Healthy Volunteer

## Interventions

- **DRUG:** ABBV-903
- **DRUG:** Midazolam

## Key facts

- **NCT ID:** NCT05895266
- **Lead sponsor:** AbbVie
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-06-23
- **Primary completion:** 2023-11-02
- **Final completion:** 2023-11-02
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2023-11-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05895266

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05895266, "A Study to Assess Drug-Drug Interaction Between ABBV-903 and Midazolam in Adult Healthy Volunteers". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT05895266. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*